Pharmacokinetics and effects on the renin-angiotensin system of ramipril in elderly patients
- 1 April 1987
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 59 (10) , D28-D32
- https://doi.org/10.1016/0002-9149(87)90049-x
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- A dose‐response study of HOE 498, a new non‐sulphydryl converting enzyme inhibitor, on blood pressure, pulse rate and the renin‐ angiotensin‐aldosterone system in normal man.British Journal of Clinical Pharmacology, 1985
- MORTALITY AND MORBIDITY RESULTS FROM THE EUROPEAN WORKING PARTY ON HIGH BLOOD PRESSURE IN THE ELDERLY TRIAL*1, *2The Lancet, 1985
- A need for new converting enzyme inhibitors?BMJ, 1985
- The effect of the converting enzyme inhibitor HOE 498 on the renin angiotensin system of normal volunteersNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1985
- Influence of range of renal function and liver disease on predictability of creatinine clearanceClinical Pharmacology & Therapeutics, 1981
- Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition.Heart, 1980
- A micro assay for active and total renin concentration in human plasma based on antibody trappingClinica Chimica Acta; International Journal of Clinical Chemistry, 1980